Literature DB >> 32219332

CTRP3 ameliorates cerulein-induced severe acute pancreatitis in mice via SIRT1/NF-κB/p53 axis.

Chunyang Lv1, Yuan He2, Mingli Wei1, Guiyun Xu1, Chuang Chen1, Zhen Xu1, Zhilong Ding1.   

Abstract

Severe acute pancreatitis (SAP) is a common and life-threatening clinical acute abdominal disease. C1q/tumor necrosis factor-related protein 3 (CTRP3), a novel paralog of adiponectin, has been identified as a crucial regulator in multiple types of inflammatory disorders. However, the biological role of CTRP3 in SAP remains poorly understood. This study aimed to characterize the role of CTRP3 in SAP and illuminate the potential mechanisms involved. In the current study, SAP mouse models were induced by seven hourly intraperitoneal injection of cerulein (50 μg/kg) and an immediate intraperitoneal injection of lipopolysaccharide (10 mg/kg) after the last cerulein administration. Histological examination and serological analysis demonstrated that SAP mouse models were successfully established. Herein, we found that CTRP3 expression was significantly decreased in the pancreatic tissues of SAP mice compared with normal control mice. Furthermore, we explored the effects of CTRP3 rescue in SAP mice and discovered that CTRP3 over-expression attenuated pathological lesions, inhibited inflammatory mediator release and repressed acinar cell apoptosis. Notably, mechanistic studies revealed that CTRP3 over-expression suppressed NF-κB p65 phosphorylation and p53 acetylation to alleviate cerulein-induced SAP in mouse models through activation of silent information regulator 1 (SIRT1), a nicotinamide adenine dinucleotide-dependent protein deacetylase. Collectively, our data indicate that CTRP3 may exert its protective effects in SAP mice via regulation of SIRT1-mediated NF-κB and p53 signaling pathways, implying a promising therapeutic strategy against SAP. Copyright 2020 The Author(s).

Entities:  

Keywords:  CTRP3; NF-κB signaling; SIRT1; p53 acetylation; severe acute pancreatitis

Year:  2020        PMID: 32219332     DOI: 10.1042/BSR20200092

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  6 in total

1.  C1q/tumor necrosis factor-related protein-3 (CTRP3) activated by forkhead box O4 (FOXO4) down-regulation protects retinal pericytes against high glucose-induced oxidative damage through nuclear factor erythroid 2-related factor 2 (Nrf2)/Nuclear factor-kappaB (NF-κB) signaling.

Authors:  XiuYa Zeng; YouYuan Peng; YanFeng Wang; KeMing Kang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

2.  Plasma C1q/tumor necrosis factor-related protein-3 concentrations are associated with diabetic peripheral neuropathy.

Authors:  Ke Lin; Liu Yang; Yuyuan Xiong; Keduo Feng; Wang Zeng; Bo Deng
Journal:  BMJ Open Diabetes Res Care       Date:  2022-04

3.  The CTRP3-AdipoR2 Axis Regulates the Development of Experimental Autoimmune Encephalomyelitis by Suppressing Th17 Cell Differentiation.

Authors:  Masanori A Murayama; Hsi-Hua Chi; Mako Matsuoka; Takahiro Ono; Yoichiro Iwakura
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

4.  KLF4 downregulates FGF21 to activate inflammatory injury and oxidative stress of LPS‑induced ATDC5 cells via SIRT1/NF‑κB/p53 signaling.

Authors:  Xi Chen; Jia Wen; Chaoqi Liu; Donggeng Guo
Journal:  Mol Med Rep       Date:  2022-03-16       Impact factor: 2.952

5.  Drug discovery and formulation development for acute pancreatitis.

Authors:  Xue Jiang; Ya-Wen Zheng; Shihui Bao; Hailin Zhang; Ruijie Chen; Qing Yao; Longfa Kou
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

6.  CTRP3 alleviates cardiac ischemia/reperfusion injury via LAMP1/JIP2/JNK signaling pathway.

Authors:  Yanbin Song; Yunqing Zhang; Zhaofei Wan; Junqiang Pan; Feng Gao; Fei Li; Jing Zhou; Junmin Chen
Journal:  Aging (Albany NY)       Date:  2022-02-03       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.